Show simple item record

dc.contributor.authorZheng, Chengyun
dc.contributor.authorYalman, Nevin
dc.contributor.authorHenter, Jan-Inge
dc.contributor.authorNordenskjold, Magnus
dc.contributor.authorGuergey, Aytemiz
dc.contributor.authoral-Lamki, Zakia
dc.contributor.authorHorne, AnnaCarin
dc.contributor.authorRamme, Kim Goransdotter
dc.contributor.authorRudd, Eva
dc.contributor.authorWali, Yasser
dc.date.accessioned2021-03-06T11:20:23Z
dc.date.available2021-03-06T11:20:23Z
dc.date.issued2008
dc.identifier.citationHorne A., Ramme K. G. , Rudd E., Zheng C., Wali Y., al-Lamki Z., Guergey A., Yalman N., Nordenskjold M., Henter J., "Characterization of PRF1, STX11 and UNC13D genotype-phenotype correlations in familial hemophagocytic lymphohistiocytosis", BRITISH JOURNAL OF HAEMATOLOGY, cilt.143, ss.75-83, 2008
dc.identifier.issn0007-1048
dc.identifier.othervv_1032021
dc.identifier.otherav_ee985676-15e6-4d3c-95e9-52922f387f8a
dc.identifier.urihttp://hdl.handle.net/20.500.12627/156618
dc.identifier.urihttps://doi.org/10.1111/j.1365-2141.2008.07315.x
dc.description.abstractFamilial hemophagocytic lymphohistiocytosis (FHL) is a rare autosomal recessive lethal condition characterized by fever, cytopenia, hepatosplenomegaly and hemophagocytosis. The hallmark of FHL is defect apoptosis triggering and lymphocyte cellular cytotoxicity. Thus far three disease-causing genes (PRF1, UNC13D, STX11) have been identified. We performed a genotype-phenotype study in a large, multi-ethnic cohort of 76 FHL patients originating from 65 unrelated families. Biallelic mutations in PRF1, UNC13D and STX11 were demonstrated in 13/74 (18%), 6/61 (10%) and 14/70 (20%) patients, respectively. In 27/60 (45%) patients analyzed for all three genes, no molecular diagnosis was established. STX11 mutations were most common in Turkish families (7/28, 25%), whereas in Middle East families, PRF1 mutations were most frequent (6/13, 46%). No biallelic mutation was identified in most families of Nordic origin (13/14, 93%). Patients carrying PRF1 mutations had higher risk of early onset (age < 6 months) compared to patients carrying STX11 mutations [adjusted odds ratio 8.23 (95% confidence interval [CI] = 1.20-56.40), P = 0.032]. Moreover, patients without identified mutations had increased risk of pathological cerebrospinal fluid (CSF) at diagnosis compared to patients with STX11 mutations [adjusted odds ratio 26.37 (CI = 1.90-366.82), P = 0.015]. These results indicate that the disease-causing mutations in FHL have different phenotypes with regard to ethnic origin, age at onset, and pathological CSF at diagnosis.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectHEMATOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectHematoloji
dc.titleCharacterization of PRF1, STX11 and UNC13D genotype-phenotype correlations in familial hemophagocytic lymphohistiocytosis
dc.typeMakale
dc.relation.journalBRITISH JOURNAL OF HAEMATOLOGY
dc.contributor.departmentKarolinska Institutet (Karolinska Institute) , ,
dc.identifier.volume143
dc.identifier.issue1
dc.identifier.startpage75
dc.identifier.endpage83
dc.contributor.firstauthorID189910


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record